A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model

Raymund R. Razonable, Nicole C.E. Aloia, Ryan J. Anderson, Gokhan Anil, Lori L. Arndt, Richard F. Arndt, Sara E. Ausman, Sarah J. Bell, Dennis M. Bierle, Marcie L. Billings, Rachel K. Bishop, Carl H. Cramer, Tracy L. Culbertson, Ala S. Dababneh, Amber N. Derr, Kevin Epps, Susan M. Flaker, Ravindra Ganesh, Mary A. Gilmer, Eric Gomez UrenaChristopher R. Gulden, Tamara L. Haack, Sara N. Hanson, Jenna R. Herzog, Alexander Heyliger, Lex D. Hokanson, Laura H. Hopkins, Richard J. Horecki, Bipinchandra Hirisave Krishna, W. Charles Huskins, Tammy A. Jackson, Ryan R. Johnson, Betty Jorgenson, Cory Kudrna, Brian D. Kennedy, Mary K. Klingsporn, Brian Kottke, Jennifer J. Larsen, Sarah R. Lessard, Larry I. Lutwick, Edward J. Malone, Jennifer A. Matoush, Ivana N. Micallef, Darcie E. Moehnke, Muhanad Mohamed, Colleena N. Ness, Shelly M. Olson, Robert Orenstein, Raj Palraj, Janki Patel, Damian J. Paulson, David Phelan, Margaret T. Peinovich, Wilford L. Ramsey, Taunya J. Rau-Kane, Kevin I. Reid, Karen J. Reinschmidt, Maria Teresa Seville, Erin C. Skold, Jill M. Smith, Leigh L. Speicher, Laurie A. Spielman, Donna J. Springer, Perry W. Sweeten, Jennifer M. Tempelis, Sidna Tulledge-Scheitel, Paschalis Vergidis, Daniel C. Whipple, Caroline G. Wilker, Molly J. Destro Borgen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model'. Together they form a unique fingerprint.

Medicine & Life Sciences